Does intensive insulin treatment reduce long-term mortality in patients with diabetes mellitus and acute myocardial infarction compared to conventional treatment?
Intensive insulin treatment reduces long-term mortality in diabetic patients with AMI, mitigating the risk associated with severe glycometabolic state at admission.
Mortality in diabetic patients with AMI is predicted by age, previous heart failure, and severity of the glycometabolic state at admission but not by conventional risk factors or sex. Intensive insulin treatment reduced long-term mortality despite high admission blood glucose and Hb AIc.
Malmberg et al. (Tue,) studied this question.